Radiation therapy for prostate cancer can damage the bundle of nerves in the lower back, called the lumbosacral plexus, though this complication is rare. According to Gram Research analysis of two detailed cases, the peak radiation dose received by the nerve bundle appears to be more important than the overall treatment dose in determining whether nerve damage occurs. One patient who received a maximum dose of 72.3 Gy to the nerve bundle developed severe, permanent nerve damage, while another patient with a lower peak dose of 58.6 Gy recovered substantially after medical management.
Radiation therapy for prostate cancer can sometimes damage nerves in the lower back and legs, a rare but serious side effect called radiation-induced lumbosacral plexopathy. Gram Research analysis of two detailed patient cases shows that the highest dose of radiation received by nerve bundles, not just the overall treatment dose, may be the key factor in whether patients develop this complication. One patient received very high radiation doses concentrated in one area and developed severe nerve damage, while another patient with lower doses in the same region recovered well after stopping certain medications. These findings suggest doctors should carefully monitor and limit radiation doses to nerve bundles during prostate cancer treatment, especially as newer imaging techniques allow for more targeted, higher-dose therapy.
Key Statistics
A case report of two prostate cancer patients published in 2026 found that a patient receiving a peak radiation dose of 72.3 Gy to the lumbosacral plexus developed severe nerve damage with progressive weakness and eventual wheelchair dependence, while a patient with a lower peak dose of 58.6 Gy to the same nerve bundle experienced substantial recovery.
In a 2026 analysis of radiation-induced nerve damage following prostate cancer therapy, the patient with focal high-dose radiation geometry (maximum dose 72.3 Gy) developed bilateral neurologic decline despite surgical decompression and immunotherapy, suggesting that maximum point dose to nerve bundles may be a critical factor in toxicity risk.
A 2026 case report documented that discontinuation of hormone therapy medication (enzalutamide) combined with rehabilitation led to substantial neurologic recovery in a prostate cancer patient with radiation-induced nerve damage, indicating that nerve complications may be partially reversible with appropriate management.
The Quick Take
- What they studied: Whether radiation therapy for prostate cancer can damage the bundle of nerves in the lower back and legs, and what dose levels cause this damage
- Who participated: Two men with prostate cancer: one age 75 treated with salvage radiation for recurrent cancer, and one age 65 treated with initial radiation for advanced cancer
- Key finding: The patient who received a peak radiation dose of 72.3 Gy to the nerve bundle developed severe, lasting nerve damage, while the patient with a peak dose of 58.6 Gy to the same area recovered substantially after stopping certain medications
- What it means for you: If you are considering or undergoing radiation therapy for prostate cancer, ask your radiation oncologist about nerve bundle protection and dose limits. This research is preliminary and based on only two cases, so discuss your individual risk with your medical team
The Research Details
This study presents two detailed case reports of patients who developed nerve damage after prostate cancer radiation therapy. The researchers reviewed each patient’s medical records, imaging scans, and radiation treatment plans in detail. They used computer software to map out where the nerve bundles were located and how much radiation dose those nerves actually received during treatment. This allowed them to compare the radiation doses the nerves received to the symptoms each patient developed. Case reports are detailed stories of individual patients rather than large studies, so they help doctors recognize patterns and raise questions for future research, but they cannot prove that one thing causes another.
Understanding what causes nerve damage from radiation therapy is important because it helps doctors design safer treatment plans. By knowing which dose levels are dangerous, doctors can adjust their radiation plans to protect nerves while still effectively treating cancer. This is especially important as newer imaging techniques allow doctors to target cancer more precisely with higher radiation doses in smaller areas.
This is a case report based on only two patients, which is the lowest level of scientific evidence. The findings cannot be generalized to all prostate cancer patients. However, the detailed dose calculations and clinical follow-up provide valuable information that can guide future research. The cases show a clear relationship between radiation dose to nerves and nerve damage, which strengthens the observations.
What the Results Show
The first patient received a peak radiation dose of 72.3 Gy to the lumbosacral plexus, a bundle of nerves in the lower back. Four weeks after treatment ended, he developed pain and weakness on one side of his body that progressed to weakness on both sides. Despite surgery to relieve pressure on the nerves, vitamin B12 supplementation, and immune system therapy, his condition worsened and he eventually needed a wheelchair. The radiation dose map showed that the highest-dose radiation area directly overlapped with the part of the nerve bundle where his symptoms started. The second patient received a peak dose of 58.6 Gy to the same nerve bundle. He developed pain and weakness in both legs one month after treatment, but his symptoms improved substantially after stopping a hormone therapy medication and completing rehabilitation. His radiation dose was lower and more spread out, without the concentrated high-dose area seen in the first patient.
The study highlights the importance of looking at the maximum point dose, not just the average dose, when assessing nerve damage risk. In the first case, even though doctors tried to redesign the radiation plan to reduce the high-dose area, the anatomy of the cancer location made it impossible to eliminate the hotspot completely. The second case shows that nerve damage from radiation is not always permanent and can improve with appropriate medical management and physical therapy. The study also emphasizes that when a patient’s symptoms get worse in unexpected ways, doctors should reconsider the radiation treatment plan and look for other contributing factors like medication side effects.
Nerve damage from pelvic radiation therapy has been described before, mostly in patients treated for gynecologic cancers like cervical or ovarian cancer, or colorectal cancer. This study adds important information about prostate cancer radiation therapy specifically. As radiation techniques have improved to allow higher, more focused doses, the risk of nerve damage may increase if doctors do not carefully protect nerve bundles. The finding that maximum point dose matters more than average dose is relatively new and suggests that previous safety guidelines based on average dose alone may not be sufficient.
This study involves only two patients, so the findings cannot be applied to all prostate cancer patients. The cases are presented after the fact, so researchers cannot control for other factors that might have contributed to nerve damage. The second patient was also taking a hormone therapy medication that can cause nerve problems, making it unclear whether the nerve damage was from radiation, the medication, or both. Longer follow-up of more patients is needed to confirm these findings and determine safe radiation dose limits for the nerve bundle.
The Bottom Line
If you are being treated with radiation therapy for prostate cancer, ask your radiation oncologist: (1) Will my treatment plan include contouring and protection of the lumbosacral plexus (the nerve bundle in my lower back)? (2) What is the maximum radiation dose my nerves will receive? (3) What symptoms should I watch for after treatment? These recommendations are based on limited evidence from two cases, so discuss your individual risk and benefits with your medical team. Confidence level: Low, based on case reports only.
Prostate cancer patients considering or undergoing radiation therapy should be aware of this potential complication. Radiation oncologists should consider these findings when planning treatment, especially for patients receiving high-dose focused radiation. Patients with symptoms of nerve damage after prostate radiation (pain, weakness, or numbness in the legs or lower back) should seek prompt evaluation. This research is less relevant for patients receiving other cancer treatments or those with prostate cancer not requiring radiation.
In both cases described, nerve symptoms appeared within one month after radiation treatment ended. The first patient’s symptoms worsened over weeks to months, while the second patient showed improvement over weeks to months with appropriate management. If nerve damage occurs, recovery may take months and may be incomplete, so early recognition and treatment are important.
Frequently Asked Questions
Can radiation therapy for prostate cancer damage nerves in my legs and lower back?
Yes, radiation therapy for prostate cancer can rarely damage the nerve bundle in the lower back called the lumbosacral plexus. A 2026 case report documented two patients who developed nerve damage after prostate radiation, with symptoms including pain, weakness, and numbness in the legs. The risk appears related to the highest radiation dose the nerves receive.
What are the symptoms of nerve damage from prostate cancer radiation?
Symptoms typically appear within one month after radiation treatment ends and include pain in the legs or lower back, weakness or difficulty walking, numbness or tingling in the legs, and sometimes difficulty controlling the bladder or bowels. Symptoms may develop on one side first and then progress to both sides.
Is nerve damage from prostate radiation therapy permanent?
Nerve damage from prostate radiation may be partially reversible. A 2026 case report showed one patient experienced substantial recovery after stopping a hormone therapy medication and completing rehabilitation, while another patient with higher radiation doses developed permanent disability despite multiple treatments.
How can doctors prevent nerve damage during prostate cancer radiation therapy?
Doctors can protect nerves by mapping the location of the nerve bundle before treatment, limiting the maximum radiation dose to the nerves, and avoiding concentrated high-dose areas overlapping with nerves when possible. A 2026 case report suggests that monitoring maximum point dose to nerves, not just average dose, is important for preventing severe nerve damage.
What should I do if I develop pain or weakness in my legs after prostate radiation?
Contact your radiation oncologist or primary care doctor immediately rather than waiting for your next scheduled appointment. Prompt evaluation by a neurologist or rehabilitation specialist may help identify the cause and start appropriate treatment. Early recognition and management may improve the chances of recovery.
Want to Apply This Research?
- If you are undergoing prostate cancer radiation therapy, use your app to track daily symptoms: leg pain (rate 0-10), leg weakness (can you walk normally, climb stairs, stand from sitting), numbness or tingling in legs or lower back, and any difficulty with bladder or bowel control. Note the date symptoms start and any changes in severity. Share this log with your doctor at follow-up appointments.
- After completing prostate radiation therapy, commit to regular physical activity as tolerated (walking, gentle stretching, physical therapy exercises if prescribed) to maintain nerve and muscle function. Report any new pain, weakness, or numbness to your doctor immediately rather than waiting for your next scheduled appointment. If prescribed, take all medications as directed and report any side effects.
- Set monthly reminders for the first year after radiation therapy to assess and log your nerve-related symptoms using the tracking suggestion above. Schedule follow-up appointments with your radiation oncologist at 1 month, 3 months, 6 months, and 12 months after treatment to discuss any symptoms. If symptoms develop, ask for referral to a neurologist or physiatrist (rehabilitation doctor) for specialized evaluation and treatment.
This article discusses a case report of two patients and represents preliminary, limited evidence. Radiation-induced nerve damage is a rare complication of prostate cancer radiation therapy. The findings from two cases cannot be generalized to all patients. If you have prostate cancer or are considering radiation therapy, discuss your individual risk factors, benefits, and potential complications with your radiation oncologist and medical team. If you develop symptoms such as pain, weakness, numbness, or loss of bladder or bowel control after radiation therapy, seek immediate medical evaluation. This article is for educational purposes only and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.